NIMOTUZUMAB: 83 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
83
Total FAERS Reports
15 (18.1%)
Deaths Reported
25
Hospitalizations
83
As Primary/Secondary Suspect
2
Life-Threatening
First Report: 20150729 · Latest Report: 20250705
What Are the Most Common NIMOTUZUMAB Side Effects?
#1 Most Reported
Myelosuppression
21 reports (25.3%)
#2 Most Reported
Disease progression
12 reports (14.5%)
#3 Most Reported
Off label use
10 reports (12.0%)
All NIMOTUZUMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 21 | 25.3% | 0 | 13 |
| Disease progression | 12 | 14.5% | 6 | 0 |
| Off label use | 10 | 12.1% | 1 | 3 |
| Product use in unapproved indication | 6 | 7.2% | 0 | 0 |
| Anaemia | 5 | 6.0% | 1 | 0 |
| Encephalitis autoimmune | 5 | 6.0% | 0 | 0 |
| Fatigue | 5 | 6.0% | 1 | 1 |
Who Reports NIMOTUZUMAB Side Effects? Age & Gender Data
Gender: 18.6% female, 81.4% male. Average age: 44.8 years. Most reports from: CN. View detailed demographics →
Is NIMOTUZUMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 1 | 0 | 0 |
| 2020 | 2 | 0 | 0 |
| 2021 | 4 | 0 | 2 |
| 2022 | 4 | 1 | 4 |
| 2023 | 3 | 0 | 2 |
| 2024 | 10 | 0 | 7 |
| 2025 | 5 | 0 | 5 |
What Is NIMOTUZUMAB Used For?
| Indication | Reports |
|---|---|
| Nasopharyngeal cancer | 18 |
| Colorectal cancer | 9 |
| Brain stem glioma | 6 |
Official FDA Label for NIMOTUZUMAB
Official prescribing information from the FDA-approved drug label.